Cresud (NASDAQ: CRESY) cleared to offer 43,735,429 shares for options

Rhea-AI Filing Summary

Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria reports that Argentina’s securities regulator has authorized the public offering of 43,735,429 ordinary shares for the future exercise of options previously approved in 2021. These shares have a nominal value of ARS 1 and carry one vote each.

This new authorization is added to the remaining balance of 32,900,367 ordinary shares from the original 90,000,000-share program tied to option exercises. Current share capital is 648,742,437 shares, and it will rise to 725,378,233 shares if all outstanding options and warrants are fully exercised.

Insights

Equity capital markets analyst

New CNV authorization ensures Cresud can honor all outstanding options.

Cresud obtained Argentine Securities Commission approval to publicly offer 43,735,429 ordinary shares linked to its existing option program. This follows the earlier authorization for 90,000,000 shares and 90,000,000 options tied to the capital increase framework set in 2019 and 2021.

The filing clarifies capital evolution: current capital is 648,742,437 shares, with 49,708,631 warrants outstanding. If every option is exercised, authorized capital for public offering will reach 725,378,233 shares, matching ARS 725,378,233 in nominal value.

The main effect is administrative alignment between option terms and available authorized shares, rather than a new discretionary issuance. Actual dilution depends on holders choosing to exercise options and warrants over time, consistent with the pre-existing program.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 FORM 6-K

 REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15b-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

For the month of February, 2026

 Cresud Sociedad Anónima, Comercial, Inmobiliaria,

Financiera y Agropecuaria

(Exact name of Registrant as specified in its charter)

Cresud Inc.

(Translation of registrant´s name into English)

 Republic of Argentina

(Jurisdiction of incorporation or organization)

Carlos Della Paolera 261

(C1001ADA)

Buenos Aires, Argentina

 (Address of principal executive offices)

 Form 20-F ⌧ Form 40-F  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes o No x

CRESUD S.A.C.I.F. and A.

(THE “COMPANY”)

REPORT ON FORM 6-K

Attached is an English translation of the letter dated February 18, 2026, filed by the Company with the Bolsa de Comercio de Buenos Aires and the Comisión Nacional de Valores.

Buenos Aires, Argentina – February 18, 2026 – Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria (the “Company”) (NASDAQ: CRESY, BYMA:CRES), informs that, within the framework of the capital increase through share subscription approved by the Shareholders’ Meeting held on October 30, 2019 and by the Board of Directors on January 20, 2021, for a total of 90,000,000 shares with a nominal value of ARS 1 and one vote per share, and 90,000,000 options granting the right to receive ordinary shares, reaching a maximum total of 180,000,000 shares to be issued, as duly authorized by Resolution No, RESFC-2021-20969-2021 APN-DIR#CNV dated February 8, 2021, issued by the Argentine Securities Commission (the “CNV”), the Company has submitted to said authority a request for authorization to issue an additional 43,735,429 shares, required in the event that all currently outstanding options are exercised.

This request responds to the need to comply with the obligations assumed by the Company and to the adjustments made to the conversion ratio in accordance with the option agreement dated March 11, 2021.

Accordingly, the public offering authorization granted by CNV Resolution No, RESFC-2026-23445-APN-DIR#CNV will allow for the proper and full exercise of the options currently outstanding, authorizing the public offering of 43,735,429 ordinary, book-entry shares, with a nominal value of ARS 1 each and one (1) vote per share, for the future exercise of the options previously authorized by Resolution No, RESFC-2021-20969-APN-DIR#CNV dated February 8, 2021, This authorization is added to the balance of 32,900,367 ordinary shares authorized under the original resolution.

 It is hereby informed that, following the capital increase, the Company’s share capital authorized for public offering will amount, in the event that all options are exercised, to ARS 725,378,233, represented by the same number of ordinary, book-entry shares with a nominal value of ARS 1 each and one (1) vote per share.

 Below is a table showing the evolution of capital and the exercise of options as of November 2025:

CRESUD	Shares
Post capital increase (2021)	591,642,804
Authorization of shares for warrant exercise	90,000,000
Authorized Capital	681,642,804
Capital Evolution and Adjustments
Post capital increase (2021)	591,642,804
Shares issued upon warrant exercise
sep-21	74,370
nov-21	163,813
feb-22	65,079
may-22	142,669
sep-22	76,391
nov-22	7,450
feb-23	1,182,290
may-23	35,017
sep-23	64,162
nov-23	720,912
feb-24	129,449
may-24	2,050,914
sep-24	2,283,822
nov-24	4,501,293
feb-25	1,908,747
may-25	9,025,091
sep-25	17,769,882
nov-25	16,898,282
Current Capital	648,742,437
Balance of shares authorized in 2021	32,900,367
Shares authorized by CNV in 2026	43,735,429
Final Capital*	725,378,233
Warrants outstanding	49,708,631
Current ratio	1.5417

 *In the event that all options are exercised

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Buenos Aires, Argentina.

	Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria
	By:	/S/ Saúl Zang
		Saúl Zang
		Responsible for the Relationship with the Markets

February 18, 2026


 
 
 
 

FAQ

What did Cresud (CRESY) announce in this Form 6-K?

Cresud announced that Argentina’s securities regulator authorized the public offering of 43,735,429 ordinary shares. These shares are reserved for future exercise of options from a capital increase program originally approved in 2019 and 2021, ensuring all outstanding options can be fully honored.

How many Cresud shares did the CNV newly authorize for option exercises?

The Argentine Securities Commission authorized 43,735,429 Cresud ordinary, book-entry shares with a nominal value of ARS 1 and one vote each. These shares are specifically tied to the future exercise of options previously approved under Resolution RESFC-2021-20969-APN-DIR#CNV dated February 8, 2021.

What is Cresud’s current share capital and potential final capital after all options are exercised?

Cresud’s current share capital is 648,742,437 ordinary shares. If all currently outstanding options and warrants are exercised, the company’s share capital authorized for public offering will increase to 725,378,233 ordinary shares, each with a nominal value of ARS 1 and one vote per share.

How does the new Cresud authorization relate to the original 2021 share program?

The new authorization of 43,735,429 shares is added to a remaining balance of 32,900,367 ordinary shares from the original 90,000,000-share authorization. Together, they ensure Cresud has enough authorized shares to cover all option exercises under the CNV’s 2021 resolution framework.

How many Cresud warrants or options remain outstanding under this program?

The capital evolution table shows that Cresud has 49,708,631 warrants outstanding. These warrants are linked to the option program approved in 2021, and the new share authorization is designed to enable proper and full exercise of these outstanding instruments if holders choose to convert.

What will Cresud’s capital look like after the 2021 and 2026 authorizations if fully used?

After the original 2021 capital increase, Cresud had 591,642,804 shares and authorization for 90,000,000 shares for warrant exercises. Following successive warrant exercises and the 2026 CNV authorization, final capital may reach 725,378,233 ordinary shares if all authorized options and warrants are exercised.